Proteonomix Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2008
2009
2010
2011
Cash & Short Term Investments
0.10
99.80
0.00
0.00
Total Accounts Receivable
137.40
41.80
15.40
20.80
Inventories
191.80
192.50
187.30
191.50
Other Current Assets
-
-
-
18.00
Total Current Assets
329.30
334.10
202.70
230.30
Net Property, Plant & Equipment
50.20
41.10
31.90
22.80
Intangible Assets
40.60
35.80
3,417.50
3,088.00
Total Assets
420.10
411.00
3,652.20
3,341.00
ST Debt & Current Portion LT Debt
504.80
392.70
1,900.00
2,377.50
Accounts Payable
1,629.40
2,359.10
2,952.60
3,355.60
Other Current Liabilities
5,709.40
2,151.20
2,242.40
1,305.50
Total Current Liabilities
7,843.60
4,903.00
7,095.00
7,038.60
Total Liabilities
7,843.60
4,903.00
7,095.00
7,038.60
Common Equity (Total)
7,423.50
4,492.30
3,443.10
3,697.80
Total Shareholders' Equity
7,423.50
4,492.00
3,442.90
3,697.60
Total Equity
7,423.50
4,492.00
3,442.90
3,697.60
Liabilities & Shareholders' Equity
420.10
411.00
3,652.20
3,341.00
Preferred Stock (Carrying Value)
-
0.30
0.30
0.30

About Proteonomix

View Profile
Address
140 East Ridgewood Avenue
Paramus New Jersey 07652
United States
Employees -
Website mailto:[email protected]
Updated 07/08/2019
Proteonomix, Inc. is a biotechnology company which engages in the discovery and development of stem cell therapeutic and cosmeceutical products. It develops pre clinical-stage therapeutic agents and treatments for diabetes, heart, and lung diseases. Proteonomix was founded by Michael Moshe Cohen on June 26, 1995 and is headquartered in Hawthorne, NJ.